How close are the practice questions to the real USMLE?

Our vignettes mirror NBME formatting and timing, with detailed step-by-step rationales and references to first-line guidelines.

Can I target weak systems or disciplines?

Yes. Create custom blocks by system (e.g., cardiovascular) and discipline (e.g., pharm, phys), plus difficulty filters.

Do you offer free content?

Join the list to unlock 50 free questions and weekly high-yield article drops. No credit card required.

EKG Arrhythmias You Can’t Miss: SVT vs Afib vs Flutter vs VT (Management First) For Step 2

How Step 2 Wants You to Think: “Unstable vs Stable” Beats Perfect Rhythm Labels

If you only memorize EKG pictures, Step 2 will punish you with management questions where the “right rhythm” is less important than the right first action. The fastest way to win SVT vs atrial fibrillation vs flutter vs VT is to anchor on two decisions that appear in nearly every tachyarrhythmia stem: (1) Is the patient unstable? and (2) Is the QRS narrow or wide? This is why the classic board sequence is always: stabilize → classify → treat.

Unstable tachycardia = electricity first

“Unstable” on exams is not a vibe—it's a checklist. Treat the rhythm as the cause if the tachyarrhythmia is producing:

Hypotension (especially with poor perfusion signs)
Altered mental status
Signs of shock (cool/clammy, delayed cap refill, oliguria)
Ischemic chest discomfort
Acute heart failure (pulmonary edema, severe dyspnea)

Exam move: if any instability criteria are present, choose synchronized cardioversion (with sedation if time).

Stable tachycardia = classify the QRS

After ABCs and a quick bedside assessment, Step 2 wants you to sort into:

Narrow (< 120 ms): usually supraventricular (SVT, AF, flutter)
Wide (≥ 120 ms): VT until proven otherwise

Then the “bonus” questions show up: regular vs irregular, visible atrial activity, and context (COPD, digoxin, WPW, post-MI scar).

Stem clue	Likely category	Management-first answer Step 2 expects
Hypotension + tachyarrhythmia	Unstable tachycardia (any rhythm)	Synchronized cardioversion (if pulse). If pulseless: defibrillation + CPR.
Regular narrow @ 180, sudden onset	SVT (AVNRT/AVRT)	Vagal maneuvers → adenosine if stable and regular.
Irregularly irregular narrow	Atrial fibrillation	Rate control (β-blocker or diltiazem) + anticoagulation decisions.
“Sawtooth” flutter waves	Atrial flutter	Often treat like AF: rate control; consider cardioversion/ablation strategy; anticoagulate.
Wide regular tachycardia	Monomorphic VT (most likely)	If stable: antiarrhythmic infusion (often procainamide/amiodarone) and expert consult; if unstable: cardioversion.

The high-yield trick: you can answer many questions without committing to the exact arrhythmia name. Example: “wide-complex tachycardia after prior MI, stable, BP okay.” Even if you’re unsure whether it is ventricular tachycardia or SVT with aberrancy, boards want you to treat it as VT because that’s the safer management path and the guideline-consistent default. The only time the exact label becomes mandatory is when the medication choice changes (e.g., AF with WPW where AV nodal blockers can precipitate VF).

EKG Pattern Recognition in 30 Seconds: What to Notice First

Step 2 stems often include a small strip that is intentionally “ugly”—baseline wander, few leads, and limited time. Build a fast scan order so you don’t overthink: Rate → Regularity → QRS width → Atrial activity → Context. Think of this like triage for your eyes: identify the features that change management immediately.

Regularity is a cheat code

Regular narrow: classic SVT (AVNRT/AVRT) or atrial flutter with fixed block (e.g., 2:1).
Irregular narrow: AF is the default; also consider multifocal atrial tachycardia in COPD.
Regular wide: monomorphic VT until proven otherwise.
Irregular wide: AF with aberrancy, polymorphic VT (torsades), or pre-excited AF (WPW) — high danger.

Board habit: if you see “irregularly irregular,” your brain should say “AF pathway.”

Atrial activity: absent, chaotic, or organized?

AF: no discrete P waves; fibrillatory baseline; irregular RR intervals.
Atrial flutter: organized atrial activity (classically “sawtooth”); ventricular rate often ~150 with 2:1 block.
SVT (AVNRT): P waves often hidden in QRS or appear as pseudo-R′ in V1 / pseudo-S in inferior leads.
VT: P waves may be dissociated; look for capture or fusion beats when shown.

Trap: flutter with 2:1 block can look like “SVT at 150.” Always hunt for flutter waves.

Context clues that steer you away from the wrong drug

COPD + irregular narrow: think multifocal atrial tachycardia; treat underlying pulmonary issue, consider verapamil.
Hyperthyroidism: AF trigger; rate control and address thyroid.
Post-op / sepsis / alcohol binge: AF is common; treat cause plus rate control.

History of WPW or short PR + delta wave baseline: avoid AV nodal blockers in AF with pre-excitation.
Long QT or torsades risk: magnesium is your reflex.
Old MI / cardiomyopathy: monomorphic VT becomes more likely than SVT with aberrancy.

A practical Step 2 heuristic: if you can’t see clear P waves and the rhythm is narrow + irregular, assume AF and move to “rate vs rhythm vs anticoagulation.” If it’s narrow + regular at a high rate with sudden onset and no obvious flutter waves, assume SVT and reach for vagal maneuvers then adenosine (if stable). If it’s wide, behave like it’s VT until someone proves otherwise.

SVT on Step 2: What “Regular Narrow Tachycardia” Usually Means

On USMLE-style questions, “SVT” is often shorthand for AV nodal re-entrant tachycardia (AVNRT) or orthodromic AV re-entrant tachycardia (AVRT). The presentation is dramatic but stable: sudden palpitations, anxiety, lightheadedness, sometimes chest tightness, and a regular narrow tachycardia commonly 160–220. The exam wants you to apply the standard escalation: vagal maneuvers → adenosine → synchronized cardioversion (if unstable or refractory).

Stable SVT algorithm (board version)

Confirm stability: no shock, no pulmonary edema, no altered mentation.
Vagal maneuvers: modified Valsalva is common in test explanations.
Adenosine: rapid IV push (then flush) for regular narrow complex tachycardia.
AV nodal blockade if needed: β-blocker or non-DHP CCB (diltiazem/verapamil), depending on clinical context.
Refractory/unstable: synchronized cardioversion.

Adenosine is both diagnostic and therapeutic for AV node–dependent re-entry.

Common SVT distractors (and how Step 2 separates them)

Panic attack: symptoms fluctuate; EKG won’t show a sustained regular tachycardia strip.
Sinus tachycardia: gradual onset/offset; identifiable P waves; treat the cause (pain, fever, anemia).
Atrial flutter (2:1): rate ~150 and very regular; look carefully for flutter waves.
VT: if QRS is wide, treat as VT.

The adenosine question is a frequent testing point. Boards like to ask: “Regular narrow tachycardia, stable; next best step?” Choose vagal maneuvers if offered; otherwise adenosine. Another classic: “Adenosine transiently slows the ventricular rate but the tachycardia resumes.” That can still be SVT; adenosine has a very short half-life. Repeat dosing may appear, or the question may be hinting that the underlying rhythm is atrial flutter—adenosine may unmask flutter waves by increasing AV block. In that case, the correct pivot is to the flutter/AF pathway (rate control and anticoagulation considerations).

High-risk exception: SVT logic changes with WPW + AF

If the stem suggests Wolff-Parkinson-White (baseline delta wave or known WPW) and the rhythm is irregular + wide (pre-excited AF), avoid AV nodal blockers (adenosine, β-blockers, diltiazem/verapamil, digoxin) because they can preferentially route conduction down the accessory pathway and precipitate ventricular fibrillation. Step 2 will reward “procainamide” or “ibutilide” (or synchronized cardioversion if unstable) in that scenario.

Finally, don’t miss the “why” behind vagal maneuvers: you are increasing parasympathetic tone to the AV node, slowing AV nodal conduction and interrupting AV node–dependent circuits. Step 2 doesn’t need electrophysiology depth, but it does love simple mechanism questions: “Which drug blocks AV nodal conduction and can terminate AVNRT?” → adenosine.

Master your USMLE prep with MDSteps.

Practice exactly how you’ll be tested—adaptive QBank, live CCS, and clarity from your data.

Start Your Free 3-Day Trial Browse features

Full Access - Free Trial - No Long Term Commitments

100+ new students last month.

What you get

Adaptive QBank with rationales that teach
CCS cases with live vitals & scoring
Progress dashboard with readiness signals

No Commitments • Free Trial • Cancel Anytime

Create your account

Atrial Fibrillation on Step 2: Rate Control, Rhythm Control, and Anticoagulation

Atrial fibrillation is the most testable irregular tachyarrhythmia because it forces you to integrate: hemodynamic stability, symptom duration, comorbidities, and thromboembolic risk. EKG is classically irregularly irregular with no discrete P waves. But Step 2 is less about “spot AF” and more about “what do you do first, safely.”

First fork: unstable vs stable

Unstable AF (shock, ischemia, pulmonary edema, altered mentation): synchronized cardioversion.
Stable AF with RVR: initial goal is ventricular rate control + evaluate triggers.

Board tip: the phrase “AF with rapid ventricular response” is a signal to choose a rate-controlling AV nodal agent unless WPW is present.

Rate control options (Step 2 practical)

β-blocker (e.g., metoprolol) is common, especially with CAD or hyperthyroid symptoms.
Non-DHP CCB (diltiazem/verapamil) is a frequent “best next step” in otherwise stable patients.
Digoxin may appear in hypotensive patients with systolic HF who cannot tolerate other agents, but it is slower.
Amiodarone may be chosen when both rate and rhythm control are needed in specific contexts (often ICU/test nuance).

Test trap: avoid non-DHP CCBs in decompensated HFrEF; boards will steer you to β-blocker (if stable) or digoxin/amiodarone depending on scenario.

The anticoagulation logic is where many students bleed points. Step 2 generally expects you to use CHA₂DS₂-VASc to decide long-term stroke prevention (and sometimes to frame pericardioversion anticoagulation). You don’t need to compute every edge case perfectly to answer most questions; you need to recognize the “automatic anticoagulation” patterns: age ≥75, prior stroke/TIA, heart failure, hypertension, diabetes, and vascular disease each raise risk. When a vignette gives you those features, it is inviting anticoagulation as part of the plan.

Cardioversion timing: the board-safe version

Electrical or pharmacologic cardioversion is an attractive “make it look normal” move, but it carries stroke risk if atrial thrombus has formed. Step 2 commonly tests the duration threshold:

AF duration > 48 hours or unknown: anticoagulate for ~3 weeks before cardioversion or use TEE-guided strategy, then anticoagulate after.
AF clearly < 48 hours: cardioversion can be considered with appropriate anticoagulation strategy based on risk and context.
Any unstable patient: cardioversion now (life over clot), then anticoagulate when safe.

Rhythm control (antiarrhythmics or ablation) is usually not the first move in typical Step 2 “new AF in the ED” questions unless the stem highlights severe symptoms despite rate control, tachycardia-induced cardiomyopathy, or a clear reversible trigger where early rhythm control is favored. More commonly, the test is satisfied with: rate control + anticoagulation assessment + treat the cause (thyrotoxicosis, infection, alcohol binge, PE, post-op stress).

Where MDSteps can help (light plug)

Arrhythmia questions are “decision-tree” problems. On the MDSteps Adaptive QBank, drilling tachyarrhythmias with structured misses → auto-generated flashcards helps you internalize the unstable/stable and narrow/wide forks so you stop guessing under time pressure.

Atrial Flutter vs Afib: How to Differentiate and Why Management Looks Similar (Until It Doesn’t)

Atrial flutter is often presented as AF’s “organized cousin.” The atria are not fibrillating chaotically; they are typically circling in a macro-reentrant loop (classically around the tricuspid annulus). The ventricular response is limited by the AV node, so you often see a regular ventricular rhythm at a predictable rate. The most common board presentation is 2:1 block with a ventricular rate near 150.

EKG clues

Flutter: sawtooth flutter waves (best in inferior leads), often regular ventricular rate.
AF: no discrete atrial waves; “irregularly irregular” RR intervals.
2:1 flutter trap: looks like SVT at 150—adenosine can unmask flutter waves by increasing AV block.

Management overlap (what Step 2 wants)

Unstable: synchronized cardioversion.
Stable: rate control with β-blocker or diltiazem/verapamil.
Anticoagulation: stroke risk principles parallel AF; board questions often treat similarly.

Translation: if you can manage AF, you can manage flutter on most Step 2 stems.

Where flutter becomes unique is in the “definitive therapy” conversation. Typical flutter circuits can be highly amenable to catheter ablation, and Step 2 may ask for long-term management in a patient with recurrent flutter despite rate control. Another nuance: flutter often conducts with fixed ratios (2:1, 3:1, variable). When the ratio changes, the ventricular rhythm becomes irregular, and flutter can mimic AF. This is why the board-safe approach is to treat the patient and the risk rather than to obsess over whether every flutter wave is visible.

“Management first” flowchart you can memorize

Tachyarrhythmia with a pulse

Unstable? → synchronized cardioversion (sedate if able)
Stable → narrow vs wide QRS
- Narrow, regular → vagal maneuvers → adenosine → AV nodal blocker
- Narrow, irregular → AF/flutter pathway: rate control + anticoagulation decision + treat trigger
- Wide → treat as VT: antiarrhythmic infusion if stable; cardioversion if unstable

This mirrors ACLS-style decision-making used in many test explanations.

The exam loves to connect flutter with structural heart disease or post-cardiac surgery settings, but you’re rarely asked to localize the circuit. More likely: “45-year-old with palpitations, sawtooth waves, stable.” If the answer choices include “diltiazem,” “metoprolol,” “synchronized cardioversion,” and “adenosine,” you decide based on stability and regularity. If stable, rate control wins; adenosine is not definitive for flutter, though it can be diagnostically useful.

Ventricular Tachycardia: Treat Wide-Complex as VT Until Proven Otherwise

Ventricular tachycardia (VT) is the “can’t miss” rhythm because the wrong medication can kill. Step 2 makes this simple: a wide-complex tachycardia is VT until you have strong evidence it’s not. Monomorphic VT is common in patients with prior MI and scar-related re-entry. Polymorphic VT includes torsades de pointes, often linked to prolonged QT and electrolyte or medication triggers.

Stable monomorphic VT (has a pulse)

Step 2 commonly tests an antiarrhythmic infusion choice and monitoring:

Procainamide or amiodarone are frequent “board-correct” options for stable wide regular tachycardia.
Consider adenosine only if the rhythm is regular and monomorphic and you suspect SVT with aberrancy.
Always include “expert consultation” in your mental model when options look similar.

If the patient becomes unstable at any point → synchronized cardioversion.

Unstable VT or pulseless VT/VF

Unstable with pulse: synchronized cardioversion.
Pulseless VT/VF: defibrillation + CPR, then epinephrine and amiodarone per ACLS sequence.
Polymorphic VT (torsades): magnesium is key; correct K/Mg, stop QT-prolonging drugs.

Wide-complex tachycardia: Step 2 “don’t get tricked” list

SVT with aberrancy: can mimic VT; if uncertain, treat as VT.
Hyperkalemia: can produce wide QRS and sine-wave patterns; calcium is lifesaving.
Pre-excited AF (WPW): irregular wide; avoid AV nodal blockers; use procainamide or cardioversion.

Torsades triggers: low Mg/K, bradycardia, QT-prolonging meds.
Capture/fusion beats: if shown, they point toward VT (ventricular origin).
Post-MI scar: makes monomorphic VT more likely.

One of the highest-yield medication safety points: don’t reflexively give diltiazem for a wide-complex tachycardia. If the rhythm is VT, AV nodal blockers won’t fix it and can worsen hemodynamics. Conversely, boards sometimes present a stable wide-regular tachycardia and offer procainamide vs amiodarone vs synchronized cardioversion. Choose cardioversion if there are instability features; otherwise select a guideline-consistent antiarrhythmic infusion and monitoring. If torsades is described (“twisting points,” long QT, syncope), magnesium is your first move.

Putting It Together: A USMLE-Style Management Matrix You Can Recreate From Memory

The fastest way to convert recognition into points is to memorize a small “matrix” of first-line actions. On exam day, you should be able to sketch this on your scratch paper in under 60 seconds: unstable vs stable; narrow vs wide; regular vs irregular. Below is a compact version that’s intentionally aligned with ACLS-style logic and common cardiology guideline framing.

Bucket	What it usually is	First move	Second move	Medication “never do”
Unstable tachycardia (pulse)	Any tachyarrhythmia causing shock/ischemia/HF/AMS	Synchronized cardioversion	Address cause + anticoagulate when indicated (AF/flutter)	Do not “trial meds” while unstable
Stable narrow regular	SVT (AVNRT/AVRT), flutter w/ fixed block	Vagal maneuvers	Adenosine → AV nodal blocker	Adenosine if irregular rhythm
Stable narrow irregular	AF (default), flutter w/ variable block, MAT	Rate control + treat trigger	Anticoagulation decision; consider rhythm strategy	AV nodal blockers in AF + WPW
Stable wide regular	Monomorphic VT (assume VT)	Antiarrhythmic infusion + consult	Cardioversion if refractory or worsens	Diltiazem/verapamil reflex
Wide irregular	Torsades, AF w/ aberrancy, pre-excited AF (WPW)	Depends: Mg for torsades; cardiovert if unstable	Correct electrolytes; stop triggers; expert help	AV nodal blockers in pre-excited AF

Classic Step 2 vignettes (and the expected “next step”)

Palpitations, sudden onset, narrow regular 190 → vagal maneuvers/adenosine.
Post-op patient, irregular narrow 140, stable → diltiazem/metoprolol + evaluate triggers.
Sawtooth 150, stable → rate control; consider anticoagulation.
Prior MI, wide regular 170, BP okay → treat as VT (procainamide/amiodarone) + consult.
Syncope, twisting wide rhythm, long QT → magnesium + correct electrolytes.

NBME-style traps

Flutter 2:1 masquerading as SVT: look for subtle flutter waves; adenosine may “reveal,” but not cure.
AF duration unknown: don’t jump straight to elective cardioversion without anticoagulation/TEE strategy.
WPW + AF: the “wrong” answer is any AV nodal blocker; choose procainamide or cardioversion.
Wide complex labeled “SVT”: ignore label; treat the EKG (wide = VT until proven otherwise).

If you want a practical way to drill this, build sets where you force yourself to answer in a single sentence: “Stable narrow irregular → rate control + anticoagulation decision.” “Unstable → synchronized cardioversion.” Repeating these one-liners is not simplistic—it mirrors how you must think under timed pressure.

Rapid-Review Checklist: The 12 Things to Know Before Your Next NBME Block

Use this list as a pre-block warm-up. If you can recite these rules and apply them to a messy strip, you’re in the “can’t miss” zone for SVT vs atrial fibrillation vs atrial flutter vs VT questions. Keep the wording tight, because that’s how the exam is written: short stems, high stakes, and only one “do this first” answer.

Exam-day essentials

Unstable tachycardia with a pulse → synchronized cardioversion (sedate if time).
Pulseless VT/VF → defibrillation + CPR (then epi and amiodarone per algorithm).
Narrow + regular → think SVT (or 2:1 flutter) → vagal maneuvers then adenosine if stable.
Narrow + irregular → think AF (default) → rate control + anticoagulation assessment + treat trigger.
Flutter at ~150 can masquerade as SVT; hunt for flutter waves, especially in inferior leads.
Wide + regular → treat as VT until proven otherwise.
Torsades (polymorphic VT + long QT) → magnesium + correct K/Mg + stop QT drugs.
AF with WPW (irregular wide, delta wave history) → avoid AV nodal blockers; use procainamide/ibutilide or cardioversion if unstable.
AF duration unknown or >48h → anticoagulate before elective cardioversion or use TEE strategy.
Non-DHP CCBs (diltiazem/verapamil) are great for AF rate control in many stable patients, but avoid in decompensated HFrEF.
Don’t treat sinus tachycardia as SVT: gradual onset/offset = treat the cause (pain, fever, anemia, hypovolemia).
When torn between two rhythms, choose the option that is safest if you’re wrong (wide complex → VT pathway).

A simple practice routine (15 minutes)

Do 10 mixed tachyarrhythmia questions timed (90 seconds each).
For every miss, write the one-liner: “Stable/unstable + narrow/wide → first move.”
Convert misses into a small flashcard set (“If irregular wide + WPW → procainamide”).

One last plug (keep it practical)

If you’re building a Step 2 schedule, an automatic plan generator that injects “arrhythmia micro-sets” every few days prevents the common decay where you recognize AF today and forget it two weeks later.

References

Medically reviewed by: Priya Shah, MD (Cardiology).